PILL — Canntab Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapSucker Stock
- CA$0.58m
- CA$2.57m
- CA$0.29m
Annual balance sheet for Canntab Therapeutics, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2018 May 31st | 2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.22 | 1.59 | 2.09 | 1.49 | 0.691 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.17 | 0.24 | 0.328 | 0.207 | 0.21 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 4.46 | 1.9 | 3.48 | 3.51 | 1.46 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.16 | 0.343 | 1.77 | 2.56 | 1.08 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 4.75 | 2.59 | 5.51 | 6.36 | 2.85 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.314 | 0.232 | 1.42 | 1.66 | 2.56 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.447 | 0.326 | 1.98 | 4.09 | 3.16 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4.3 | 2.27 | 3.53 | 2.27 | -0.311 |
| Total Liabilities & Shareholders' Equity | 4.75 | 2.59 | 5.51 | 6.36 | 2.85 |
| Total Common Shares Outstanding |